Sabby Management
Sabby Management reported 16 stocks worth $12M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are SPY (34.2%), TOYO (29.1%) and FAMI (7.0%). Compared with Q1 2026, the fund opened new positions in TOYO, FAMI and CRVO, added to SPY, TPST and BCTX, trimmed SNES, BCTXL and INM and sold out of DSY, TC and CPOP.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  SPY Spdr S&P 500 ETF TR | $4.1M | 34.2% | 5,500 | +2,766 (+101%) | 5 of 8 | |
| 2 |  TOYO Toyo Co Ltd | $3.5M | 29.1% | 504K | New position | 1 of 8 | |
| 3 |  FAMI Farmmi Inc | $840K | 7.0% | 3.5M | New position | 1 of 8 | |
| 4 |  CRVO Cervomed Inc | $772K | 6.4% | 249K | New position | 1 of 8 | |
| 5 |  TPST Tempest Therapeutics Inc | $568K | 4.7% | 511K | +493K (+2763%) | 4 of 8 | |
| 6 |  PAVS Paranovus Entertnmnt Tech LT | $561K | 4.7% | 75K | New position | 1 of 8 | |
| 7 | BIOAFFINITY TECHNOLOGIES INC | $297K | 2.5% | 366K | New position | 2 of 8 | |
| 8 |  CREG Smart Powerr Corp | $263K | 2.2% | 128K | New position | 1 of 8 | |
| 9 |  BCTX Briacell Therapeutics Corp (ca) | $262K | 2.2% | 81K | +6,806 (+9%) | 2 of 8 | |
| 10 | Revelation Biosciences Inc | $217K | 1.8% | 211K | +111K (+112%) | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
PORTAGE BIOTECH INC | $655K | 2.1M |
 DSY Big Tree Cloud Hldgs Ltd | $337K | 138K |
 TC Token Cat Ltd | $242K | 23K |
 CPOP Pop Culture Group Co Ltd | $201K | 664K |
 MBRX Moleculin Biotech Inc | $172K | 75K |
🔒 Free account: see all 14.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
SPY Spdr S&P 500 ETF TR | Put | $54.1M | 725 | +278 |
SPY Spdr S&P 500 ETF TR | Call | $15.3M | 205 | +205 |
 OEF Ishares TR | Call | $13.3M | 442 | +442 |
OEF Iwm 270115P00240000 | Put | $13.2M | 441 | +141 |
 ABVX Abivax SA | Call | $1.1M | 82 | +5 |
🔒 Free account: see all 7.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Sabby Management 13F FAQ
What does Sabby Management own?
Sabby Management reported 16 stocks worth $12M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are SPY (34.2%), TOYO (29.1%) and FAMI (7.0%). The table above lists every position in the filing (the top 10 without an account).
What did Sabby Management buy and sell in Q2 2026?
Compared with Q1 2026: 8 new positions, 4 added to, 4 trimmed and 14 sold out. New positions include TOYO, FAMI and CRVO. It sold all of DSY, TC and CPOP.
When will Sabby Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Sabby Management's portfolio worth?
The Q2 2026 filing reports $12M in US stocks ($111M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.